SLC6A8 and neuroblastoma: BCL11B, which was previously shown by microarrays and rt-PCR to be downregulated in PD blood[11] was also downregulated in rotenone-treated neuroblastomas, and so was the creatine neurotransmitter transporter SLC6A8.